Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00112151 · ClinicalTrials.gov registry record · Phase 2
TEAM: Testosterone Supplementation and Exercise in Elderly Men
A Phase 2 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 167
- Enrollment target
NCT00112151 is a Phase 2 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 167 participants.
The verdict
NCT00112151, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 167 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
Interventions
- DRUG Placebo
- BEHAVIORAL Resistance Training
- DRUG LowT
- DRUG HighT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2005-01 |
| Est. Completion | 2010-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00112151
The ClinicalTrials.gov registry entry for NCT00112151 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00112151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00112151 about?
NCT00112151 is a clinical study titled "TEAM: Testosterone Supplementation and Exercise in Elderly Men". The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
What is the current status of trial NCT00112151?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 167 participants. The study started on 2005-01. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00112151?
The interventions under investigation include: Placebo (DRUG), Resistance Training (BEHAVIORAL), LowT (DRUG), HighT (DRUG).
Who is sponsoring clinical trial NCT00112151?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.